SS
NRXP icon

SBI Securities’s NRX Pharmaceuticals NRXP Stock Holding History

SBI Securities’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9K Buy
5,101
+2,601
+104% +$8.59K ﹤0.01% 1533
2026
Q1 		$5.33K Hold
2,500
– – ﹤0.01% 2000
2025
Q4 		$6.78K Hold
2,500
– – ﹤0.01% 1898
2025
Q3 		$8.25K Sell
2,500
-892
-26% -$2.55K ﹤0.01% 1855
2025
Q2 		$11.1K Buy
3,392
+1,392
+70% +$3.49K ﹤0.01% 1664
2025
Q1 		$4.1K Buy
+2,000
New +$5.63K ﹤0.01% 1975

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities's NRXP Position: Q2 2026 in Review

SBI Securities increased its NRX Pharmaceuticals (NRXP) stake by 104% in Q2 2026, buying an estimated $8.59K and bringing the position to 5,101 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1533.

SBI Securities first reported a position in NRXP in Q1 2025 and has held it in 6 quarters since. 46 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • SBI Securities held 5,101 shares of NRX Pharmaceuticals worth $20.9K as of Q2 2026.
  • SBI Securities bought 2,601 NRX Pharmaceuticals shares in Q2 2026, an estimated $8.59K.
  • NRX Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1533 holding.
  • SBI Securities first reported a position in NRX Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 46 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.